tiprankstipranks
Advertisement
Advertisement
mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley
PremiumThe FlymRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley
7d ago
BioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review
Premium
Company Announcements
BioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review
7d ago
BioNTech drops 9% after ending Phase 2 colorectal cancer trial
Premium
The Fly
BioNTech drops 9% after ending Phase 2 colorectal cancer trial
7d ago
BioNTech: Cash-Rich Oncology Pipeline Supports Sentiment, But Clinical and Valuation Uncertainties Warrant Hold Rating
PremiumRatingsBioNTech: Cash-Rich Oncology Pipeline Supports Sentiment, But Clinical and Valuation Uncertainties Warrant Hold Rating
15d ago
BioNTech to Unveil Novel Lung Cancer Combination Data at WCLC 2026
Premium
Company Announcements
BioNTech to Unveil Novel Lung Cancer Combination Data at WCLC 2026
15d ago
BioNTech rises 20.3%
Premium
The Fly
BioNTech rises 20.3%
16d ago
Trump signs EO to split up of childhood vaccines, Bloomberg reports
PremiumThe FlyTrump signs EO to split up of childhood vaccines, Bloomberg reports
25d ago
Pfizer and BioNTech Advance Variant-Adapted COVID-19 Booster in New Phase 4 Study
Premium
Company Announcements
Pfizer and BioNTech Advance Variant-Adapted COVID-19 Booster in New Phase 4 Study
28d ago
Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update
Premium
Company Announcements
Pfizer and BioNTech Advance Next‑Season Pediatric COVID‑19 Booster Strategy With New Phase 3 Update
28d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100